Prediction of Pathological Stage in Patients with Clinical Stage T1c Prostate Cancer: The New Challenge-Reference-Cited by-同舟云学术

Prediction of Pathological Stage in Patients with Clinical Stage T1c Prostate Cancer: The New Challenge

Published:2002-07 Issue:1 Volume:168 Page:100-104
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Veltri Robert W.¹,Miller M. Craig¹,Mangold Leslie A.¹,O’dowd Gerard J.¹,Epstein Jonathan I.¹,Partin Alan W.¹

Affiliation:

1. From The Brady Urological Institute of The Johns Hopkins Medical Institutions, Baltimore, Maryland, Immunicon Corp., Huntingdon Valley, Pennsylvania, and UroCor, Inc., Oklahoma City, Oklahoma

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference21 articles.

1. Cancer Statistics, 2000;Greenlee;CA Cancer J Clin,2000

2. Prostate cancer incidence and mortality rates among white and black men;Merrill;Epidemiology,1997

3. Analysis of repeated biopsy results within one year following a noncancer diagnosis;O’Dowd;Urology,2000

4. Natural history of progression after PSA elevation following radical prostatectomy;Pound;JAMA,1999

5. Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis;Shipley;JAMA,1999

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nuclear Morphometry, Epigenetic Changes, and Clinical Relevance in Prostate Cancer;Cancer Biology and the Nuclear Envelope;2014

2. Nuclear morphometry, nucleomics and prostate cancer progression;Asian Journal of Andrology;2012-04-16

3. Validation of Epstein criteria of insignificant prostate cancer in Middle East patients;International Urology and Nephrology;2009-11-10

4. Validation of the Contemporary Epstein Criteria for Insignificant Prostate Cancer in European Men;European Urology;2008-12

5. The role of magnetic resonance imaging (MRI) in prostate cancer imaging and staging at 1.5 and 3 Tesla: The Beth Israel Deaconess Medical Center (BIDMC) approach;Cancer Biomarkers;2008-11-04